Control group % (No. reaching therapeutic objectives/n) Intervention group % (No. reaching therapeutic objectives/n)
p value
Primary outcome
per protocol 33.3% (13/39) 61.7% (21/34)
0.015 a *
Intent to treat (ITT)
“Best case scenario” 29.5% (13/44) 71.1% (32/45)
<0.0001a
“Worst case scenario” 40.9% (18/44) 46.7% (21/45)
0.584a
Secondary outcomes
Number of chronic disease
1
50.0% (4/8) 77.7% (7/9)
0.335b
2
33.3% (3/9) 70.0% (7/10)
0.179b
>2
27.3% (6/22) 46.7% (7/15)
0.225a
Number of prescribed drugs
< 5
60.0% (9/15) 64.3% (9/14)
0.812a
≥5
16.7% (4/24) 60.0% (12/20)
0.005b *
Social level
1
37.5% (6/16) 37.5% (3/8)
1b
2
33.3% (2/6) 70.0% (7/10)
0.302b
3
29.4% (5/17) 68.8% (11/16)
0.024a *
Age (yr)
<60
50.0% (7/14) 66.7% (10/15)
0.362a
≥60
26.1% (6/23) 57.9% (11/19)
0.037a *
Study disease
Hypertension
38.5% (10/26) 62.5% (15/24)
0.089a
Type II diabetes
10.0% (1/10) 33.3% (3/9)
0.303b
Hypercholesterolemia
37.5% (3/8) 80.0% (4/5)
0.266b